Table 2 Patient outcomes and management
Severity of sepsis | N (%) |
|---|---|
Sepsis without organ failure | 214 (57.4) |
Severe sepsis | 111 (29.8) |
Septic shock | 48 (12.9) |
Pitt bacteremia score | |
0 | 127 (34.0) |
1 | 115 (30.8) |
2 | 65 (17.4) |
≥3 | 66 (17.7) |
All-cause mortality | |
7-day | 54 (14.5) |
30-day | 102 (27.3) |
90-day | 135 (36.2) |
Empiric antibiotic management | |
Penicillin plus aminoglycoside | 65 (17.3) |
Cefuroxime-containing regimens | 63 (16.9) |
Dicloxacillin-containing regimens | 62 (16.6) |
Penicillin monotherapy | 52 (13.9) |
Cefotaxime-containing regimens | 47 (12.7) |
Other treatment | 73 (19.6) |
No treatment | 11 (2.9) |
Inefficient treatment | 57 (15.3) |
Definitive antibiotic treatment* | |
Penicillin plus aminoglycoside | 18 (4.8) |
Dicloxacillin-containing regimens | 190 (51.0) |
Penicillin monotherapy | 34 (9.1) |
Cefuroxime-containing regimens | 29 (7.9) |
Cefotaxime-containing regimens | 28 (7.6) |
Other treatment | 62 (16.7) |
No treatment | 10 (2.7) |
Inefficient treatment | 11 (2.9) |
Median antibiotic treatment duration (interquartile range)$ | |
Intravenous treatment (N = 351) | 10 days (5–15) |
Total antibiotic treatment duration (N = 331) | 14 days (10–25) |
Aminoglycoside treatment (N = 117) | 3 days (2–7) |
Other management | |
Received surgical treatment | 119 (31.9) |
Treatment in Intensive Care Unit (ICU)/High dependency unit | 92 (24.7) |
Treatment with vasopressors | 39 (10.5) |
Ventilator treatment | 15 (4) |
Examined with echocardiography | 134 (35.9) |
Median length of stay (interquartile range) | 13 days (7–22) |